We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCMI icon
1201
National CineMedia
NCMI
$371M
$2.49M 0.01%
+53,938
New +$2.38M
SST icon
1202
System1
SST
$15.4M
$2.49M 0.01%
24,999
KLR
1203
DELISTED
Kaleyra, Inc.
KLR
$2.48M 0.01%
+50,265
New +$2.58M
OI icon
1204
O-I Glass
OI
$1.46B
$2.48M 0.01%
+168,039
New +$2.16M
OMEG
1205
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.48M 0.01%
+250,000
New +$2.6M
FHI icon
1206
Federated Hermes
FHI
$4.57B
$2.47M 0.01%
78,811
-219,871
-74% -$6.46M
HCII
1207
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$2.46M 0.01%
+249,980
New +$2.46M
MRSN
1208
DELISTED
Mersana Therapeutics
MRSN
$2.46M 0.01%
6,084
+2,120
+53% +$1.03M
NAGE
1209
Niagen Bioscience
NAGE
$261M
$2.46M 0.01%
+262,842
New +$2.08M
ACIC.WS
1210
CALL
DELISTED
Atlas Crest Investment Corp.Redeemable warrants included as part of the units, each whole warrant ex
ACIC.WS
$2.45M 0.01%
+244,137
New +$621K
LII icon
1211
Lennox International
LII
$19.2B
$2.45M 0.01%
7,865
-12,810
-62% -$3.71M
VICI icon
1212
VICI Properties
VICI
$30B
$2.45M 0.01%
86,790
-210,947
-71% -$5.72M
ABLLW
1213
CALL
DELISTED
Abacus Life Warrant
ABLLW
$2.45M 0.01%
250,307
AVXL icon
1214
Anavex Life Sciences
AVXL
$237M
$2.44M 0.01%
+163,087
New +$1.78M
PMGMW
1215
CALL
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$2.44M 0.01%
+249,995
New +$184K
CRS icon
1216
Carpenter Technology
CRS
$27.8B
$2.43M 0.01%
59,128
-50,743
-46% -$1.93M
MOND
1217
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$2.42M 0.01%
+249,994
New +$2.43M
AEAC
1218
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$2.42M 0.01%
+249,988
New +$2.43M
GFX.WS
1219
CALL
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$2.42M 0.01%
+249,997
New +$320K
SSL icon
1220
Sasol
SSL
$7.08B
$2.41M 0.01%
166,551
+154,341
+1,264% +$1.97M
EAC
1221
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$2.41M 0.01%
+249,988
New +$2.44M
BKI
1222
DELISTED
Black Knight, Inc. Common Stock
BKI
$2.41M 0.01%
32,594
-5,566
-15% -$448K
TACA.WS
1223
CALL
DELISTED
Trepont Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordin
TACA.WS
$2.41M 0.01%
+245,827
New +$330K
ITW icon
1224
Illinois Tool Works
ITW
$85.6B
$2.41M 0.01%
10,878
+173
+2% +$35.9K
RRD
1225
DELISTED
RR Donnelley & Sons Co.
RRD
$2.41M 0.01%
593,070
+567,426
+2,213% +$1.8M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.